Skip to main content
. 2016 Dec 7;215(12):1898–1907. doi: 10.1093/infdis/jiw545

Table 1.

Demographic and Clinical Information and Human Immunodeficiency Virus (HIV)/Kaposi’s Sarcoma–Associated Herpesvirus (KSHV) Status Among Study Patients

Subject Age, y Sex Cause of Deatha Received ART Serostatusb KSHV-Specific PCR/Southern Blot Result, by Brain Regionb
HIV KSHV FL PL TL OL Hip Cer BG
92 32 Male Tuberculosis No + + + + +
111 19 Male RVD and anemia Yes + +
116 44 Male Meningitis, R/0 tuberculosis No + + + + + + + + +
221 26 Female CNS OI, malaria, metabolic derangements Yes + +
228 34 Female RVD, tuberculosis-associated meningitis No + +
230 30 Male Hemiplegia, RVD, possible toxoplasmosis No + + +
283 34 Female RVD, tuberculosis Yes + +
315 24 Male RVD, meningitis No + +
320 40 Female Disseminated tuberculosis Unknown + +
321 35 Female Peripheral neuropathy and disseminated tuberculosis Unknown + + +
231 34 Male RVD, toxic epidermal necrolysis Yes +
001 47 Male Homicide/murder No

Abbreviations: ART, antiretroviral therapy; CNS, central nervous system; BG, basal ganglia; Cer, cerebellum; FL, frontal lobe; Hip, hippocampus; OI, opportunistic infection; OL, occipital lobe; PCR, polymerase chain reaction; PL, parietal lobe; RVD, retroviral disease; TL, temporal lobe.

aBased on report from University Teaching Hospital (Lusaka).

bA plus sign indicates seropositivity for HIV/KSHV antibody or a positive result of KSHV-specific PCR and Southern blot in various brain tissue specimens, and a minus sign indicates seronegativity for HIV/KSHV antibody or a negative result of KSHV-specific PCR and Southern blot in various brain tissue specimens.